Supratarsal injection

Schematic diagram of the human eye en

Supratarsal injection is a medical procedure involving the administration of medication directly into the eye area, specifically into the supratarsal space located above the tarsal plate of the eyelid. This technique is primarily used in the treatment of severe or refractory ocular inflammation, such as chronic or allergic conjunctivitis, and certain forms of uveitis. The procedure is notable for its ability to deliver corticosteroids or other anti-inflammatory agents directly to the affected area, providing rapid and targeted relief from inflammation and its symptoms.

Indications

Supratarsal injections are indicated for patients with persistent ocular inflammation who have not responded adequately to topical or systemic treatments. Conditions that may warrant this procedure include:

• Severe allergic conjunctivitis
• Chronic posterior uveitis
• Certain types of blepharitis that are resistant to other forms of treatment

Procedure

The supratarsal injection procedure is typically performed under local anesthesia to minimize discomfort. The steps include:

1. The area around the eye is cleaned and sterilized to prevent infection.
2. A local anesthetic is applied to numb the area.
3. A fine needle is used to inject the medication into the supratarsal space, which is located above the tarsal plate of the upper eyelid.
4. The medication is usually a corticosteroid, chosen for its potent anti-inflammatory effects.

Risks and Complications

As with any medical procedure, supratarsal injections carry some risks, including:

• Infection
• Bleeding
• Eye pain or discomfort
• Possible elevation of intraocular pressure, which can lead to glaucoma
• Rarely, perforation of the eyeball

Patients are typically monitored closely following the procedure for any signs of adverse effects or complications.

Benefits

The primary benefit of a supratarsal injection is the direct and potent delivery of medication to the inflamed ocular tissues, which can lead to:

• Rapid reduction in inflammation and related symptoms
• Decreased need for systemic medication, thereby reducing the risk of systemic side effects
• Improved quality of life for patients with chronic ocular conditions

Conclusion

Supratarsal injections offer a valuable treatment option for patients with severe or treatment-resistant ocular inflammation. By delivering medication directly to the site of inflammation, this procedure can provide rapid relief and improve outcomes for patients with challenging ocular conditions. However, it is important for patients to be fully informed of the potential risks and to be monitored closely by their healthcare provider following the procedure.